latest news releases from the newsroom
ML Laboratories Renews PER.C6(TM) License Agreement with Crucell
LEIDEN, The Netherlands, March 16, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that UK-based ML Laboratories has decided to renew its PER.C6(tm) technology license agreement. Under the renewed agreement, the parties have negotiated research and commercial terms for gene therapy products developed and manufactured on PER.C6(tm) technology. Further details were not disclosed.
Biotech Stock Review
Top 10 Performing Biotech Stocks According to Biotech Stock Review
BEVERLY HILLS, Calif., March 15, 2004 (PRIMEZONE) -- The Biotech Stock Review issued the "Top 10 Performing Biotech Stocks" list, for the week ending 3/12/2004. For the prior three month period, the Top 10 Performing Biotech Stocks gained an average of 127%. During the same time-period the average Biotech stock gained 11%, vs. a gain of 2% for the NASDAQ 100.
Medifast Announces Record Revenue and Pre-Tax Profits for 4th Quarter and 2003 Year-End
OWINGS MILLS, Md., March 15, 2004 (PRIMEZONE) -- Medifast, Inc. (AMEX:MED) reported today record fourth quarter and fiscal 2003 full-year revenues and pre-tax earnings for the period and year ended December 31, 2003. The Company reported fourth quarter revenues of $5.84 million, a 30% increase versus the same period in the year-earlier period. Medifast reported pre-tax Income from Operations of $511,000, or $0.06 per share ($0.05 per share on a fully diluted basis), a 190% increase versus $176,000, or $0.03 per share ($0.02 per share on a fully diluted basis) for the fourth quarter of 2002.
TradingSolutions.com, Inc. Executes Agreement to Merge with Chembio Diagnostic Systems, Inc.
SOLANA BEACH, Calif., March 15, 2004 (PRIMEZONE) -- TradingSolutions.com, Inc. ("TSUN") (OTCBB:TSUN) announced that it has executed a definitive Agreement and Plan of Merger ("Agreement") with Chembio Diagnostic Systems, Inc. ("Chembio"), a Delaware corporation, based in Medford, New York.
Resonate Identity Services
Robots Invade Georgia as 2,000 Spectators Watch:
ATLANTA, March 15, 2004 (PRIMEZONE) -- While NASA robots Spirit and Opportunity are hard at work on Mars, talented kids and their mentors from across the region will invade Georgia as the Peachtree Regional FIRST Robotics competition makes Atlanta its home for the second year on March 18 through 20 at the Gwinnett Center in Duluth. NASA supports regional FIRST programs, like the Peachtree Regional, all across the US because it is trying to fill the pipe line with future astronauts and technicians to work on the future space programs. Dr. Dave Lavery, Program Executive for Solar System Exploration at NASA HQ says, "This competition is a wonderful way to translate student interest in science, technology and engineering from a theoretical classroom activity into reality, and is just one of the ways NASA hopes to inspire the next generation of explorers and inventors," said Lavery.